Literature DB >> 8551623

Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.

U Utz1, D Banks, S Jacobson, W E Biddison.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive neurological disease characterized by marked degeneration of the spinal cord and the presence of antibodies against HTLV-1. Patients with HAM/TSP, but not asymptomatic carriers, show very high precursor frequencies of HTLV-1-specific CD8+ T cells in peripheral blood and cerebrospinal fluid, suggestive of a role of these T cells in the pathogenesis of the disease. In HLA-A2+ HAM/TSP patients, HTLV-1-specific T cells were demonstrated to be directed predominantly against one HTLV-1 epitope, namely, Tax11-19. In the present study, we analyzed HLA-A2-restricted HTLV-1 Tax11-19-specific cytotoxic T cells from three patients with HAM/TSP. An analysis of the T-cell receptor (TCR) repertoire of these cells revealed an absence of restricted variable (V) region usage. Different combinations of TCR V alpha and V beta genes were utilized between, but also within, the individual patients for the recognition of Tax11-19. Sequence analysis of the TCR showed evidence for an oligoclonal expansion of few founder T cells in each patient. Apparent structural motifs were identified for the CDR3 regions of the TCR beta chains. One T-cell clone could be detected within the same patient over a period of 3 years. We suggest that these in vivo clonally expanded T cells might play a role in the pathogenesis of HAM/TSP and provide information on HTLV-1-specific TCR which may elucidate the nature of the T cells that infiltrate the central nervous system in HAM/TSP patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551623      PMCID: PMC189887     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Strong similarities in antigen fine specificity among DRB1* 1302-restricted tetanus toxin tt830-843-specific TCRs in spite of highly heterogeneous CDR3.

Authors:  B Boitel; U Blank; D Mège; G Corradin; J Sidney; A Sette; O Acuto
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

2.  Dynamic changes of accumulated T cell clonotypes during antigenic stimulation in vivo and in vitro.

Authors:  K Masuko; T Kato; Y Ikeda; M Okubo; Y Mizushima; K Nishioka; K Yamamoto
Journal:  Int Immunol       Date:  1994-12       Impact factor: 4.823

Review 3.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

4.  T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome.

Authors:  J C Vernant; G Buisson; J Magdeleine; J De Thore; A Jouannelle; C Neisson-Vernant; N Monplaisir
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

5.  Identity of HTLV-I-associated tropical spastic paraparesis and HTLV-I-associated myelopathy.

Authors:  G C Román; M Osame
Journal:  Lancet       Date:  1988-03-19       Impact factor: 79.321

6.  What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis?

Authors:  P Höllsberg; D A Hafler
Journal:  Ann Neurol       Date:  1995-02       Impact factor: 10.422

7.  Crystal structure of the beta chain of a T cell antigen receptor.

Authors:  G A Bentley; G Boulot; K Karjalainen; R A Mariuzza
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

8.  Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis.

Authors:  S S Zamvil; D J Mitchell; N E Lee; A C Moore; M K Waldor; K Sakai; J B Rothbard; H O McDevitt; L Steinman; H Acha-Orbea
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

9.  Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.

Authors:  K T Hogan; N Shimojo; S F Walk; V H Engelhard; W L Maloy; J E Coligan; W E Biddison
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  H Hara; M Morita; T Iwaki; T Hatae; Y Itoyama; T Kitamoto; S Akizuki; I Goto; T Watanabe
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  31 in total

1.  Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.

Authors:  Ryuji Kubota; Samantha S Soldan; Roland Martin; Steven Jacobson
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

2.  Stoichiometry of the T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum.

Authors:  Matthew E Call; Jason Pyrdol; Kai W Wucherpfennig
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

3.  Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.

Authors:  David H Aggen; Adam S Chervin; Francis K Insaidoo; Kurt H Piepenbrink; Brian M Baker; David M Kranz
Journal:  Protein Eng Des Sel       Date:  2010-12-14       Impact factor: 1.650

4.  Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.

Authors:  Mireia Sospedra; Paolo A Muraro; Irena Stefanová; Yingdong Zhao; Katherine Chung; Yili Li; Marc Giulianotti; Richard Simon; Roy Mariuzza; Clemencia Pinilla; Roland Martin
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

5.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

6.  Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.

Authors:  Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

7.  A comprehensive calorimetric investigation of an entropically driven T cell receptor-peptide/major histocompatibility complex interaction.

Authors:  Kathryn M Armstrong; Brian M Baker
Journal:  Biophys J       Date:  2007-04-20       Impact factor: 4.033

8.  Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations.

Authors:  M C Mingari; F Schiavetti; M Ponte; C Vitale; E Maggi; S Romagnani; J Demarest; G Pantaleo; A S Fauci; L Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

9.  Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

Authors:  Paolo A Muraro; Klaus-Peter Wandinger; Bibiana Bielekova; Bruno Gran; Adriana Marques; Ursula Utz; Henry F McFarland; Steve Jacobson; Roland Martin
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

10.  Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner.

Authors:  Kurt H Piepenbrink; Oleg Y Borbulevych; Ruth F Sommese; John Clemens; Kathryn M Armstrong; Clare Desmond; Priscilla Do; Brian M Baker
Journal:  Biochem J       Date:  2009-10-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.